Bird & Bird advises CDP Venture Capital on Series A investment into Naturbeads

International law firm Bird & Bird has advised CDP Venture Capital, the largest venture capital manager in Italy, in connection with its recent investment in UK start-up Naturbeads, as part of a £7.8 million Series A round.

Naturbeads, a Bath University-founded startup, produces biodegradable cellulose microspheres as an alternative to microplastics in various products including cosmetics, detergents, and paints. Their innovative approach aims to reduce environmental pollution by replacing harmful microplastics with sustainable, natural materials.

The Series A funding round will allow Naturbeads to further develop its pioneering technology that aims to address worldwide microplastic pollution.

CDP Venture Capital, headquartered in Rome, Italy, is a venture capital firm that invests in seed-stage, early-stage, growth-stage, and later-stage companies across various sectors. These include consumer products, energy, healthcare, and technology.

The Bird & Bird team consisted of partners Adam Meisels (Corporate, London) and Calogero Porrello (Corporate, Milan), and associates Benjamin Simon (Corporate, London), Sara Calamitosi (Corporate, Milan) and Caitlin Cowan (Corporate, London).

Adam Meisels, lead partner on the transaction, commented: “We are pleased to have assisted CDP with this investment. Recent studies on the dangers of microplastics to both wildlife and the human population underscore the importance of this transaction. Additionally, this deal highlights Bird & Bird’s sector-leading expertise in the sustainability sector.”

News & Deals

More News & Deals
Deal Bird & Bird advises the African Development Bank on €100 million financing to strengthen the cocoa sector in Ivory Coast

Dec 18 2025

Read More
Deal Bird & Bird advises ASX-listed Flight Centre Travel Group on its acquisition of Iglu

Dec 17 2025

Read More
Deal Bird & Bird advises Pathos Communications plc on its AIM IPO

Dec 17 2025

Read More
Deal Bird & Bird advises Orphalan on the acquisition of Orphelia Pharma

Dec 16 2025

Read More
Deal Bird & Bird ATMD advises SuperX on Strategic Investment in NVIDIA Solution Provider MicroInference

Dec 15 2025

Read More
Deal Bird & Bird advises OSL on acquisition by Terma A/S to create leading counter-drone security platform

Dec 11 2025

Read More

Related capabilities